ClinicalTrials.gg
Sign In

Meningomyelocele clinical trials

The registry lists 58 studies for Meningomyelocele across more than 10 countries. 14 are recruiting or about to start. 28 of them are mainly about Meningomyelocele (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Meningomyelocele studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
24
Recruiting
11
Status unknown
9
Active, not recruiting
8
Terminated
3
Not yet recruiting
2

Phase

Phase 1
4
Phase 2
3
Phase 4
1
Phase 3
1

Where

United States
28
France
5
Switzerland
4
Turkey
4
Egypt
3
Belgium
2

Who runs them

The University of Texas Health Science Center, Houston (4) · Baylor College of Medicine (3) · University Children's Hospital, Zurich (3) · Assistance Publique - Hôpitaux de Paris (3) · Assiut University (3) · Mayo Clinic (2) · St. Louis University (2) · University Hospital, Lille (1)

What is being tested here

Drugs under test in Meningomyelocele studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Vibegron111
Darifenacin001
Botulinum toxin type A001
Limosilactobacillus reuteri RC-14001
Lacticaseibacillus rhamnosus GR-1001

Coming up

1phase 3 study under way
2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Who these studies take

Of the 11 Meningomyelocele studies recruiting now, 5 (45%) set no upper age limit and 6 (55%) stop at 75 or younger. 6 (55%) take children under 18. 3 (27%) are for women only and 0 (0%) for men only; 2 (18%) take healthy volunteers.

Recruiting studies that take each age, of 11
AgeWomenMen
104 (36%)4 (36%)
187 (64%)4 (36%)
306 (55%)3 (27%)
406 (55%)3 (27%)
506 (55%)3 (27%)
656 (55%)3 (27%)
755 (45%)2 (18%)
855 (45%)2 (18%)

Across all 58 studies, recruiting or not: 69% stop at 75 or younger and 69% at 65; 59% take children; 34% are for women only and 0% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Meningomyelocele studies take

Of 25 interventional studies with no phase under Meningomyelocele, half reached primary completion within 52 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase52 mo32–84 · 25 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 58. Browse all 58 → or search them.